𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of calf thymosin F-5 in the treatment of 12 cases of leukemia complicated with acute infection

✍ Scribed by X.Y. Zhao; C.X. Zheng; S.L. Liu


Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
52 KB
Volume
4
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Use of arsenic trioxide (As2O3) in the t
✍ Guillermo Lazo; Hagop Kantarjian; Elihu Estey; Deborah Thomas; Susan O'Brien; Jo πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

## Abstract ## BACKGROUND Approximately 20–30% of patients with acute promyelocytic leukemia (APL) who are treated with all‐__trans__ retinoic acid (ATRA) and an anthracycline develop recurrent disease. It has been reported that arsenic trioxide (As~2~O~3~) is effective in this setting. The author

Leukostasis followed by hemorrhage compl
✍ Jens U. WΓΌrthner; Gabriele KΓΆhler; Dirk Behringer; Albrecht Lindemann; Roland Me πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 504 KB

## Background: Pulmonary and cerebral leukostasis, or parenchymal hemorrhage in these organs, are well-known early complications developing in patients with acute myeloid leukemia (aml), particularly when myelomonocytic features, hyperleukocytosis, and/or a coagulation disorder are initially presen

Plasmapheresis in the treatment of acute
✍ David Wuest; Dennis Goldflnger πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 301 KB

Neurologic complications, including both the acute and chronic forms of inflammatory demyelinating polyradiculoneuropathy (IDP) are becoming more prevalent among patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related-complex (ARC). Although the etiology of the above radiculoneu

A comparison of two schedules of cytosin
✍ Slevin, M. L. ;Rohatiner, A. Z. S. ;Dhaliwal, H. S. ;Henry, G. P. ;Bell, R. ;Lis πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 368 KB πŸ‘ 1 views

The most effective schedule of cytosine arabinoside (Ara-C) administration remains controversial and is further confused by the use of combination chemotherapy. Two remission induction regimens comprising adriamycin, Ara-C, and 6-thioguanine have been compared in patients with acute myelogenous leuk